Dominari Holdings Inc. (NASDAQ:DOMH) Short Interest Up 396.4% in January

Dominari Holdings Inc. (NASDAQ:DOMH) was the recipient of a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 41,200 shares, a growth of 396.4% from the December 31st total of 8,300 shares. Approximately 1.2% of the shares of the company are short sold. Based on an average trading volume of 27,200 shares, the days-to-cover ratio is presently 1.5 days.

Dominari Trading Up 7.0 %

Shares of NASDAQ DOMH traded up $0.16 during trading on Thursday, reaching $2.43. 91,096 shares of the company traded hands, compared to its average volume of 130,101. Dominari has a 12-month low of $0.83 and a 12-month high of $3.20. The stock has a market cap of $15.41 million, a P/E ratio of -0.63 and a beta of 1.03. The firm’s fifty day simple moving average is $1.41 and its 200 day simple moving average is $1.63.

Dominari (NASDAQ:DOMH) last released its quarterly earnings results on Friday, November 8th. The company reported ($0.45) EPS for the quarter. Dominari had a negative net margin of 180.22% and a negative return on equity of 32.89%. The firm had revenue of $4.04 million for the quarter.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.